BioScreening - organic compounds for screening

13.07.2006 New Tool Can Boost or Block the Body’s Protective Inner Barriers
A team of experts funded by the National Institutes of Health (NIH) has developed a chemical tool that allows scientists to manipulate control of the passage of […]
More bioscreening news...

13.07.2006 New Risk Factors Do Not Improve Assessment of Coronary Heart Disease
Newswise — Screening for levels of C-reactive protein and other compounds recently found to be associated with coronary heart disease may not help physicians predict risk for the condition with any more accuracy than traditional major risk factors, according to a report in the July 10 issue of Archives of Internal Medicine, one of the […]
More bioscreening news...

18.07.2006 AnaSpec Develops Industry’s Only HTS Assay Kits for Screening HCV NS3/4A
Hepatitis C virus (HCV), belonging to the Flaviviridae family of positive, single stranded RNA, infects approximately 170 million people worldwide (1). The HCV polyprotein consists of structural proteins (C, E1, E2 and p7), and the non-structural (NS) proteins (NS2, NS3, NS4A, NS4B, NS5A, and […]
More bioscreening news...

18.07.2006 ELNS & Laboratory Informatics 2006
The 6th Annual ELNs meeting has been designed to reflect the shift in priorities surrounding ELNs. To achieve optimum ROI on an investment you […]
More bioscreening news...

18.07.2006 Labcyte Issued 26th U. S. Patent Describing Reduction of Electrostatic Charge to Ensure Proper Volume Transfer and Trajectory
Sunnyvale, CA, July 11, 2006 – Labcyte Inc. announces the issuance of U.S. Patent 7,070,260. This patent describes the use of deionization of microplates and reservoirs to ensure improved precision and accuracy of acoustic droplet ejection (ADE) and other techniques employing the transfer of small fluid droplets. Plastic multi-well microplates such as those commonly […]
More bioscreening news...

21.07.2006 Giving worms a taste of their own medicine
The humble nematode worm could prove invaluable in screening new compounds for active drugs, new research published today suggests. Soil-dwelling nematodes have a programmed avoidance response to harmful chemicals, which they detect through nerves exposed to their environment. Scientists led by the Wellcome Trust Sanger Institute have genetically modified the worm C. elegans to make human […]
More bioscreening news...

new | june 2010 | october 2009 | may 2009 | january 2009 | october 2008 | april 2008 | january 2008 | october 2007 | september 2007 | august 2007 | march 2007 | february 2007 | january 2007 | december 2007 | september 2006 | august 2006 | july 2006 | june 2006 | may 2006 | april 2006 | march 2006 | january 2006 | november 2005 | august 2005 | july 2005 | june 2005 | may 2005 | april 2005 | march 2005 | december 2005 | november 2004 | october 2004 | september 2004 | august 2004 | july 2004 | june 2004 | may 2004 | april 2004 | march 2004 | february 2004 | january 2004 | december 2004 | november 2003 | october 2003 | september 2003 | august 2003 | july 2003 | june 2003 | may 2003